Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Item
http://www.wikidata.org/entity/Q35067882
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot studyDecision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS)Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study.Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational studyPerception of risk and shared decision making process in multiple sclerosis.Natalizumab treatment of multiple sclerosis: new insights.Personality traits predict perceived health-related quality of life in persons with multiple sclerosis.Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.Health-related quality of life in multiple sclerosis: temperament outweighs EDSS.
P2860

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

Item
http://www.wikidata.org/entity/Q35067882
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@ast
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@en
type
label
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@ast
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@en
prefLabel
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@ast
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Risk acceptance in multiple sclerosis patients on natalizumab treatment
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0082796
P407
P433
P478
P50
P577
P5875
P698
P932